Handoko, K., Neppach, A., Snyder, I., Karim, H.T., Dombrovski, A.Y., & Peciña, M. (2025). Expectancy-Mood Neural Dynamics Predict Mechanisms of Short- and Long-Term Antidepressant Placebo Effects. Biol Psychiatry Cogn Neurosci Neuroimaging, 10(8), 794-803.Elsevier. doi: 10.1016/j.bpsc.2025.01.002.
Woody, M.L., Rohac, R., Cooper, I., Griffo, A., McDonald, N., Spotts, C., Fournier, J., Jones, N., Peciña, M., Young, K., Shivanekar, S., Rengasamy, M., Grafton, B., & Price, R.B. (2025). The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies. Biol Psychiatry, 97(8), 835-842.Elsevier. doi: 10.1016/j.biopsych.2024.10.024.
Agabio, R., Lopez-Pelayo, H., Bruguera, P., Huang, S.Y., Sardo, S., Pecina, M., Krupitsky, E.M., Fitzmaurice, G.M., & Lin, Z. (2024). Efficacy of medications for the treatment of alcohol use disorder (AUD): A systematic review and meta-analysis considering baseline AUD severity. Pharmacol Res, 209, 107454.Elsevier. doi: 10.1016/j.phrs.2024.107454.
Peciña, M., Chen, J., Karp, J.F., & Dombrovski, A.Y. (2023). Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood. JAMA Psychiatry, 80(4), 389-398.American Medical Association (AMA). doi: 10.1001/jamapsychiatry.2023.0010.
Gerlach, A.R., Karim, H.T., Peciña, M., Ajilore, O., Taylor, W.D., Butters, M.A., & Andreescu, C. (2022). MRI predictors of pharmacotherapy response in major depressive disorder. Neuroimage Clin, 36, 103157.Elsevier. doi: 10.1016/j.nicl.2022.103157.
Evans, K., Colloca, L., Pecina, M., & Katz, N. (2021). What can be done to control the placebo response in clinical trials? A narrative review. Contemp Clin Trials, 107, 106503.Elsevier. doi: 10.1016/j.cct.2021.106503.
Peciña, M., Chen, J., Lyew, T., Karp, J.F., & Dombrovski, A.Y. (2021). μ Opioid Antagonist Naltrexone Partially Abolishes the Antidepressant Placebo Effect and Reduces Orbitofrontal Cortex Encoding of Reinforcement. Biol Psychiatry Cogn Neurosci Neuroimaging, 6(10), 1002-1012.Elsevier. doi: 10.1016/j.bpsc.2021.02.009.
Chen, J., Mizuno, A., Lyew, T., Karim, H.T., Karp, J.F., Dombrovski, A.Y., & Peciña, M. (2020). Naltrexone modulates contextual processing in depression. Neuropsychopharmacology, 45(12), 2070-2078.Springer Nature. doi: 10.1038/s41386-020-00809-2.
Stahl, S.T., Jung, C., Weiner, D.K., Peciña, M., & Karp, J.F. (2020). Opioid Exposure Negatively Affects Antidepressant Response to Venlafaxine in Older Adults with Chronic Low Back Pain and Depression. Pain Med, 21(8), 1538-1545.Oxford University Press (OUP). doi: 10.1093/pm/pnz279.
Brown, V., & Peciña, M. (2019). Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities. Front Psychiatry, 10, 669.Frontiers. doi: 10.3389/fpsyt.2019.00669.
Lin, C., Karim, H.T., Pecina, M., Aizenstein, H.J., Lenze, E.J., Blumberger, D.M., Mulsant, B.H., Kharasch, E.D., Reynolds Iii, C.F., & Karp, J.F. (2019). Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression. Neuroimage Clin, 21, 101679.Elsevier. doi: 10.1016/j.nicl.2019.101679.
Peciña, M., Karp, J.F., Mathew, S., Todtenkopf, M.S., Ehrich, E.W., & Zubieta, J.K. (2019). Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches. Mol Psychiatry, 24(4), 576-587.Springer Nature. doi: 10.1038/s41380-018-0117-2.
Pecina, M., & Zubieta, J.K. (2018). Expectancy Modulation of Opioid Neurotransmission. In NEUROBIOLOGY OF THE PLACEBO EFFECT, PT I. 138, (pp. 17-37).Elsevier. doi: 10.1016/bs.irn.2018.02.003.
Peciña, M., Heffernan, J., Wilson, J., Zubieta, J.K., & Dombrovski, A.Y. (2018). Prefrontal expectancy and reinforcement-driven antidepressant placebo effects. Transl Psychiatry, 8(1), 222.Springer Nature. doi: 10.1038/s41398-018-0263-y.
Wilson, R.P., Colizzi, M., Bossong, M.G., Allen, P., Kempton, M., MTAC, & Bhattacharyya, S. (2018). Correction to: The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task. Neuropsychol Rev, 28(4), 507-508.Springer Nature. doi: 10.1007/s11065-018-9390-8.
Wilson, R.P., Colizzi, M., Bossong, M.G., Allen, P., Kempton, M., MTAC, & Bhattacharyya, S. (2018). The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task. Neuropsychol Rev, 28(4), 496-506.Springer Nature. doi: 10.1007/s11065-018-9385-5.
Peciña, M., Sikora, M., Avery, E.T., Heffernan, J., Peciña, S., Mickey, B.J., & Zubieta, J.K. (2017). Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response. Eur Neuropsychopharmacol, 27(10), 977-986.Elsevier. doi: 10.1016/j.euroneuro.2017.08.427.
Jacobs, R.H., Barba, A., Gowins, J.R., Klumpp, H., Jenkins, L.M., Mickey, B.J., Ajilore, O., Peciña, M., Sikora, M., Ryan, K.A., Hsu, D.T., Welsh, R.C., Zubieta, J.K., Phan, K.L., & Langenecker, S.A. (2016). Decoupling of the amygdala to other salience network regions in adolescent-onset recurrent major depressive disorder. Psychol Med, 46(5), 1055-1067.Cambridge University Press (CUP). doi: 10.1017/S0033291715002615.
Kassel, M.T., Rao, J.A., Walker, S.J., Briceño, E.M., Gabriel, L.B., Weldon, A.L., Avery, E.T., Haase, B.D., Peciña, M., Considine, C.M., Noll, D.C., Bieliauskas, L.A., Starkman, M.N., Zubieta, J.K., Welsh, R.C., Giordani, B., Weisenbach, S.L., & Langenecker, S.A. (2016). Decreased Fronto-Limbic Activation and Disrupted Semantic-Cued List Learning in Major Depressive Disorder. J Int Neuropsychol Soc, 22(4), 412-425.Cambridge University Press (CUP). doi: 10.1017/S1355617716000023.
Mickey, B.J., Heffernan, J., Heisel, C., Peciña, M., Hsu, D.T., Zubieta, J.K., & Love, T.M. (2016). Oxytocin modulates hemodynamic responses to monetary incentives in humans. Psychopharmacology (Berl), 233(23-24), 3905-3919.Springer Nature. doi: 10.1007/s00213-016-4423-6.
Romero, M., Aguilar, J.M., Del-Rey-Mejías, Á., Mayoral, F., Rapado, M., Peciña, M., Barbancho, M.Á., Ruiz-Veguilla, M., & Lara, J.P. (2016). Psychiatric comorbidities in autism spectrum disorder: A comparative study between DSM-IV-TR and DSM-5 diagnosis. Int J Clin Health Psychol, 16(3), 266-275.Elsevier. doi: 10.1016/j.ijchp.2016.03.001.
Martikainen, I.K., Nuechterlein, E.B., Peciña, M., Love, T.M., Cummiford, C.M., Green, C.R., Stohler, C.S., & Zubieta, J.K. (2015). Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum. J Neurosci, 35(27), 9957-9965.Society for Neuroscience. doi: 10.1523/JNEUROSCI.4605-14.2015.
Peciña, M., & Zubieta, J.K. (2015). Molecular mechanisms of placebo responses in humans. Mol Psychiatry, 20(4), 416-423.Springer Nature. doi: 10.1038/mp.2014.164.
Peciña, M., Bohnert, A.S.B., Sikora, M., Avery, E.T., Langenecker, S.A., Mickey, B.J., & Zubieta, J.K. (2015). Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression. JAMA Psychiatry, 72(11), 1087-1094.American Medical Association (AMA). doi: 10.1001/jamapsychiatry.2015.1335.
Peciña, M., Love, T., Stohler, C.S., Goldman, D., & Zubieta, J.K. (2015). Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures. Neuropsychopharmacology, 40(4), 957-965.Springer Nature. doi: 10.1038/npp.2014.272.
Schallmo, M.P., Kassel, M.T., Weisenbach, S.L., Walker, S.J., Guidotti-Breting, L.M., Rao, J.A., Hazlett, K.E., Considine, C.M., Sethi, G., Vats, N., Pecina, M., Welsh, R.C., Starkman, M.N., Giordani, B., & Langenecker, S.A. (2015). A new semantic list learning task to probe functioning of the Papez circuit. J Clin Exp Neuropsychol, 37(8), 816-833.Taylor & Francis. doi: 10.1080/13803395.2015.1052732.
Peciña, M., Martínez-Jauand, M., Hodgkinson, C., Stohler, C.S., Goldman, D., & Zubieta, J.K. (2014). FAAH selectively influences placebo effects. Mol Psychiatry, 19(3), 385-391.Springer Nature. doi: 10.1038/mp.2013.124.
Peciña, M., Martínez-Jauand, M., Love, T., Heffernan, J., Montoya, P., Hodgkinson, C., Stohler, C.S., Goldman, D., & Zubieta, J.K. (2014). Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans. J Neurosci, 34(17), 5874-5881.Society for Neuroscience. doi: 10.1523/JNEUROSCI.2152-13.2014.
Peciña, M., Stohler, C.S., & Zubieta, J.K. (2014). Neurobiology of placebo effects: expectations or learning?. Soc Cogn Affect Neurosci, 9(7), 1013-1021.Oxford University Press (OUP). doi: 10.1093/scan/nst079.
Briceño, E.M., Weisenbach, S.L., Rapport, L.J., Hazlett, K.E., Bieliauskas, L.A., Haase, B.D., Ransom, M.T., Brinkman, M.L., Peciña, M., Schteingart, D.E., Starkman, M.N., Giordani, B., Welsh, R.C., Noll, D.C., Zubieta, J.K., & Langenecker, S.A. (2013). Shifted inferior frontal laterality in women with major depressive disorder is related to emotion-processing deficits. Psychol Med, 43(7), 1433-1445.Cambridge University Press (CUP). doi: 10.1017/S0033291712002176.
Martikainen, I.K., Peciña, M., Love, T.M., Nuechterlein, E.B., Cummiford, C.M., Green, C.R., Harris, R.E., Stohler, C.S., & Zubieta, J.K. (2013). Alterations in endogenous opioid functional measures in chronic back pain. J Neurosci, 33(37), 14729-14737.Society for Neuroscience. doi: 10.1523/JNEUROSCI.1400-13.2013.
Peciña, M., & Zubieta, J.K. (2013). Molecular Mechanisms of Placebo Responses in Humans. In Placebo and Pain. (pp. 25-36).Elsevier. doi: 10.1016/b978-0-12-397928-5.00004-0.
Peciña, M., Azhar, H., Love, T.M., Lu, T., Fredrickson, B.L., Stohler, C.S., & Zubieta, J.K. (2013). Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology, 38(4), 639-646.Springer Nature. doi: 10.1038/npp.2012.227.
Peciña, M., Mickey, B.J., Love, T., Wang, H., Langenecker, S.A., Hodgkinson, C., Shen, P.H., Villafuerte, S., Hsu, D., Weisenbach, S.L., Stohler, C.S., Goldman, D., & Zubieta, J.K. (2013). DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience. Cortex, 49(3), 877-890.Elsevier. doi: 10.1016/j.cortex.2012.01.010.
Peciña, M., Stohler, C.S., & Zubieta, J.K. (2013). Role of μ-opioid system in the formation of memory of placebo responses. Mol Psychiatry, 18(2), 135-137.Springer Nature. doi: 10.1038/mp.2012.16.
Hsu, D.T., Mickey, B.J., Langenecker, S.A., Heitzeg, M.M., Love, T.M., Wang, H., Kennedy, S.E., Peciña, M., Shafir, T., Hodgkinson, C.A., Enoch, M.A., Goldman, D., & Zubieta, J.K. (2012). Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing. J Neurosci, 32(9), 3253-3260.Society for Neuroscience. doi: 10.1523/JNEUROSCI.5533-11.2012.
Love, T.M., Enoch, M.A., Hodgkinson, C.A., Peciña, M., Mickey, B., Koeppe, R.A., Stohler, C.S., Goldman, D., & Zubieta, J.K. (2012). Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner. Biol Psychiatry, 72(3), 198-206.Elsevier. doi: 10.1016/j.biopsych.2012.01.033.
Mickey, B.J., Zhou, Z., Heitzeg, M.M., Heinz, E., Hodgkinson, C.A., Hsu, D.T., Langenecker, S.A., Love, T.M., Peciña, M., Shafir, T., Stohler, C.S., Goldman, D., & Zubieta, J.K. (2011). Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry, 68(2), 158-166.American Medical Association (AMA). doi: 10.1001/archgenpsychiatry.2010.197.
Pecina, M., Lyew, T., Wilson, J., Karp, J., & Dombrovski, A. (2018). Expectancies and Reinforcement Manipulations of Mood Improvement. In BIOLOGICAL PSYCHIATRY, 83(9), (pp. S124-S125).Elsevier. doi: 10.1016/j.biopsych.2018.02.326.
Pecina, M., Heffernan, J., Avery, E., Villalobos, K., Wilson, J., Aizenstein, H., & Dombrovski, A. (2017). Internal and External Expectancies Shape Placebo-Induced Activation of the Salience Network in Depression. In BIOLOGICAL PSYCHIATRY, 81(10), (p. S159).Elsevier. doi: 10.1016/j.biopsych.2017.02.407.